Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Prevention of Post-Polypectomy Colorectal Bleeding by Clips in Patients on Anticoagulants

This observational study aims to retrospectively determine if clips can prevent post-polypectomy bleeding in adults who have received restarted anticoagulants after a colorectal polypectomy, using a large, single-center patient registry. The main question it aims to answer is: Can clips prevent post-polypectomy bleeding in adults who have received restarted anticoagulants after a colorectal polypectomy? Researchers will compare adults who received preventive clipping after a polypectomy with those who did not, regarding colorectal bleeding after receiving restarted anticoagulants. Participants have undergone a colorectal polypectomy and received restarted anticoagulants (acetylsalicylic acid excluded) after the procedure.

Participants needed: 10,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Helios Kliniken SchwerinUpdated: Jun 18, 2025Locations: 1Duration: 30 Days
Eligibility criteria

adult who has received a colonoscopy with endoscopic colorectal polypectomy [+1]

Endoscopic polypectomy was combined with closure of the mucosal defect by a sutu...

Status: Not yet recruiting

SmartGlass-Guided ERCP with Cannulation of Native Papilla 1.0

The aim of this prospective randomized study is to evaluate whether telemedical assistance via SmartGlasses is equivalent to physical presence in teaching Endoscopic Retrograde Cholangiopancreaticography (ERCP) in terms of examination success and safety. Endoscopic papilla cannulation is a key skill for successful ERCP and therefore a measurable primary endpoint of the study. This can be measured as the time (in seconds/minutes) between stable visualization of the papilla and successful endoscopic cannulation of the target structure (bile duct or pancreatic duct).

Participants needed: 170
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Helios Kliniken SchwerinUpdated: Nov 12, 2024Locations: 1
Eligibility criteria

Adult patients aged ≥ 18 years without previous papillotomy

Cannulation of the minor papilla necessary [+5]